Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation
暂无分享,去创建一个
F. Debellé | A. Massart | Quentin Mat | S. Aydın | L. Ghisdal | O. Mat | A. Goubella | F. Gankam | Niko Blankoff
[1] G. Blancho,et al. Atypical HUS relapse triggered by COVID-19 , 2020, Kidney International.
[2] J. Cerny,et al. Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19 , 2020, Journal of Thrombosis and Thrombolysis.
[3] J. Merrill,et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications , 2020, Nature Reviews Rheumatology.
[4] Agati,et al. Kidney Biopsy Findings in Patients with COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.
[5] N. Hajizadeh,et al. Thrombotic microangiopathy in a patient with COVID-19 , 2020, Kidney International.
[6] R. Brodsky,et al. Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily , 2020, British journal of haematology.
[7] Cheng Wan,et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China , 2020, Kidney International.
[8] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[9] P. Bruneval,et al. A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.